Verkuil, Arie Hans
E-Mail-Adresse
Geburtsdatum
Projekt
Organisationseinheiten
Berufsbeschreibung
Nachname
Vorname
Name
Suchergebnisse
Religious roots of the concept of mindfulness as a reference point for ethical leadership
2022, Verkuil, Arie Hans
Case Roodee LMS
2021, Kunsapsak, Chutikarn, Milow, Uta, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans
Case Study, innovative learning management platform, Malaysia
Case Jinn-Bot Robotics Design GmbH
2021, Reineke, Rolf-Dieter, Seeberger, Roger, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans
Case Study «Derma2go»
2020, Eisenbart, Barbara, Verkuil, Arie Hans, Meyer, Rolf, Aeschbacher, Marc
Case biogas and solar service provider
2021, Syed, Obed Rashdi, Milow, Uta, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans
Case Brextor
2021, Reineke, Rolf-Dieter, Portmann, Alois, Reber, Marcel, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans
Religiöse Wurzeln des Achtsamkeitskonzepts als Bezugspunkt für ethische Führung
2021, Verkuil, Arie Hans
Der Artikel reflektiert die buddhistische, hinduistische und christliche Tradition des Achtsamkeitskonzepts als Bezugspunkt für ethische Führung.
Case WAWTA (app for the blind)
2021, Raksasakul, Punchaya, Milow, Uta, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans
Case Study "Perseo Pharma"
2020, Kabous, Laila, Verkuil, Arie Hans, Meyer, Rolf, Aeschbacher, Marc
Founded in 2019, Perseo Pharma is a preclinical-stage biotech company with a unique asset for the development of enzyme therapies. Perseo Pharma possesses an innovative and proprietary enzyme shielding technology. Founded as independent spin-off of INOFEA AG, the company focuses on therapeutic enzymes for the treatment of cancer and rare genetic diseases. Over the past three decades, 30 therapeutic enzymes have been approved by EMA and FDA generating yearly 40bn. Therapeutic enzymes address a wide variety of indications, ranging from rare genetic diseases (enzyme replacement therapies) to oncology (key tumor-element depletion therapies). This offers biotech companies different opportunities and application fields for further development of enzyme therapeutics. The goal of this research is to analyze the case based on the 7-key model and provide recommendations on the financing opportunities available for Perseo pharma.